- Brand Name: Gilenya® (U.S.) (je-LEN-yah)
- Chemical Name: fingolimod (fin-GOL-i-mod)
- Usage in MS: Disease-Modifying Agent
- Generic Available: Yes
This is an oral medication in capsule form.
Description
Gilenya® is a new class of medication called a sphingosine 1-phosphate receptor modulator, which is thought to act by retaining certain white blood cells (lymphocytes) in the lymph nodes, thereby preventing those cells from crossing the blood-brain barrier into the central nervous system (CNS). Preventing the entry of these cells into the CNS reduces inflammatory damage to nerve cells.
Gilenya was approved by the U.S. Food and Drug Administration (FDA) for treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.
Click here to read the Gilenya Prescribing Information for healthcare professionals.
Click here to read the Gilenya Medication Guide for patients.
Financial Assistance Program
For co-pay assistance, contact 1-855-443-1759.